Epstein-barr Virus-positive Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus-positive Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: SynKIR-310 for Relapsed/Refractory B-NHL [Phase 1]
Phase 1 trial update for SynKIR-310 in relapsed/refractory B-cell non-Hodgkin lymphoma is currently recruiting.
-
CLINICAL_TRIALS other · 2026-03-05Clinical Trial Update: Pembro Plus CAR T-cell Therapy in R/R in PMBCL [Phase 2]
Phase 2 clinical trial evaluating pembrolizumab in combination with CAR T-cell therapy for relapsed/refractory primary mediastinal large B-c…
-
CLINICAL_TRIALS trial_result · 2020-10-22Clinical Trial Update: Study of Ibrutinib in Combination With Rituximab-CHOP in Epstein-Barr Virus-positive Diffuse Large B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating ibrutinib plus Rituximab-CHOP in Epstein-Barr virus-positive diffuse large B-cell lymphoma has completed.